2025 annual financial data
Q32 Bio 2025 Revenue growth
Direct answer
Revenue growth was Not calculable.
Operating income was 16,902,000 USD and net income was 29,821,000 USD.
Operating cash flow was -33,543,000 USD.
Get free Q32 Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 53,737,000 USD
- Operating income
- 16,902,000 USD
- Net income
- 29,821,000 USD
- Operating cash flow
- -33,543,000 USD